AGILE THERAPEUTICS INC
PRINCETON, NJ · CIK 0001261249 · Biotech · Acquired
Transdermal contraceptive patches using proprietary Skinfusion technology
agiletherapeutics.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $81M
- 8 Form D · Mar 2019
- 91 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 22
- 2 granted · 20 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓200920112013201520172019
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $1,005,000 | |
| Private capital raised | Form D · SEC | $1,010,822 | |
| Private capital raised | Form D · SEC | $989,178 | |
| Private capital raised | Form D · SEC | $23,344,028 | |
| Private capital raised | Form D · SEC | $23,676,000 | |
| Private capital raised | Form D · SEC | $3,000,000 | |
| Private capital raised | Form D · SEC | $20,000,000 | |
| Private capital raised | Form D · SEC | $7,836,878 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1785 | Function Therapeutics, Inc. | — | — |
| 1786 | SmartLife, Inc. | — | $225K |
| 1787 | Evofem Biosciences, Inc. | — | $86M |
| 1788 | AGILE THERAPEUTICS INC | — | $81M |
| 1789 | Neurogastrx, Inc. | — | $80M |
| 1790 | Azafaros | — | — |
| 1791 | Faknostics, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Al AltomariDirector · Executive Officer
- Russell AyresDirector
- Daria BlackwellDirector
- Scott CoianteExecutive Officer
- Robert ConwayExecutive Officer
- Seth FischerDirector
- Elizabeth GarnerExecutive Officer
- Geoffrey GilmoreExecutive Officer
- Karen HongDirector
- John HubbardDirector
- Devang KantesariaDirector
- Abhijeet LeleDirector
- Abhijeet LeLeDirector
- Katie MacFarlaneExecutive Officer
- William McKeeDirector
- Dean MillerDirector
- Lorenzo PellegriniDirector
- Thomas RossiDirector · Executive Officer
- Andrew SchiffDirector
- Paul SchmittDirector
- Ajit ShettyDirector
- Joyce TsangDirector
- James TursiDirector
Patents
- Transdermal Packaging Membranesgranted
- Dermal Delivery Devicegranted
- Contraceptive Compositions and Methods for Improved Efficacy and Modulation of Side Effectsapplication
- Transdermal Deliveryapplication
- Transdermal Deliveryapplication
- Personalized Contraceptive Formulationsapplication
- Transdermal Contraceptive Hormones Deliveryapplication
- Transdermal Contraceptive Hormones Deliveryapplication
- Dermal Delivery Compositions And Methodsapplication
- Dermal Delivery Deviceapplication
- Transdermal Contraceptive Hormones Deliveryapplication
- Transdermal Contraceptive Hormones Deliveryapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.